Astrana Health (ASTH) late Thursday reported a Q4 net loss of $0.15 per diluted share, compared with earnings of $0.26 a year earlier.
Analysts polled by FactSet expected earnings of $0.10.
Revenue for the quarter ended Dec. 31 was $665.2 million up from $353 million a year earlier.
Analysts surveyed by FactSet expected $617.2 million.
The company expects 2025 revenue in the range of $2.5 billion to $2.7 billion. Analysts expected $2.58 billion.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.